Mode
Text Size
Log in / Sign up

Pilot qualitative study explores pathways and acceptability of cash transfers for low-income patients with hypertension or diabetesCould giving cash to patients with high blood pressure or diabetes help their health?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note: Qualitative pilot data suggest cash transfers may work via multiple pathways; health outcomes were not measured.

This was a pilot randomized controlled trial with a qualitative sub-study component. It enrolled 100 low-income Pennsylvania Medicaid beneficiaries aged 18 or older with a diagnosis of pre-diabetes, diabetes, and/or hypertension who were prescribed at least one oral medication for these conditions. The study compared an unconditional cash transfer intervention to standard of care over a 12-week follow-up period, with 93 participants attending follow-up and 34 completing qualitative interviews.

The primary outcome was not reported. The qualitative sub-study explored secondary outcomes, including pathways through which cash transfers may influence health and the intervention's acceptability and feasibility. Participants reported that cash transfers were primarily used to address basic needs. They identified potential pathways for health improvement, including temporary reductions in stress and anxiety, changes in diet and physical activity, improved medication adherence, and increased healthcare seeking behavior. The intervention was viewed as highly acceptable by recipients.

Safety and tolerability data were not reported. Key limitations include the study's nature as a pilot and a qualitative sub-study, meaning it was not designed to measure quantitative health outcomes. The findings suggest unconditional cash transfers may improve health for patients with chronic diseases through a variety of pathways that should be measured in future trials. The practice relevance is restrained, as this research identifies potential mechanisms and demonstrates feasibility for future, larger-scale investigations.

What if the best medicine for managing a chronic condition isn't just a pill, but money to pay the rent? A small, early study in Philadelphia gave 100 low-income patients with high blood pressure or diabetes a cash transfer, no questions asked, alongside their regular medical care. The researchers then talked in-depth with 34 of them to understand what happened.

Patients overwhelmingly used the money to cover basic needs like food, utilities, and transportation. But they also described how this financial breathing room opened up potential pathways to better health. Many felt a temporary lift in stress and anxiety, which can worsen conditions like hypertension. Some reported eating better, being more active, taking their medications more consistently, and even seeking more healthcare because they could afford the co-pays or bus fare.

It's crucial to understand what this study does and doesn't show. The patients found the program highly acceptable, and even those who didn't receive cash felt the selection process was fair. However, this was a qualitative pilot study—it listened to people's experiences to identify possible mechanisms, not to measure concrete health improvements. No data was collected on whether blood pressure or blood sugar actually went down. The findings point to promising avenues for future, larger trials that would need to track those specific health outcomes to see if giving cash truly makes a medical difference.

What this means for you:
Early study finds giving cash to patients may reduce stress and help them manage chronic disease, but health benefits aren't yet proven.

Study Details

Study typeRct
Sample sizen = 100
EvidenceLevel 2
Follow-up216.0 mo
PublishedApr 2026
View Original Abstract ↓
Unconditional cash transfers are a popular poverty reduction approach and may influence behavioral risk factors for chronic disease outcomes through economic and psychological pathways. Few studies have used qualitative interviews to identify the mechanisms through which cash transfers delivered in a health care context might influence the health of people living with chronic diseases in the United States. We conducted a pilot randomized controlled trial to identify pathways through which unconditional cash transfers may influence health and assess the acceptability and feasibility of such an intervention among low-income patients receiving treatment for hypertension or diabetes. Inclusion criteria were: ≥1 visit at the Penn Family Care clinic within the six months prior to study start, ≥18 years of age, Pennsylvania Medicaid beneficiary, diagnosis of pre-diabetes or diabetes, and/or hypertension, prescribed ≥1 oral medication for diabetes or hypertension, and no plans to leave the Philadelphia metro area. Participants were randomized to either the standard of care or an unconditional cash transfer intervention, and completed an assessment at enrollment and after 12 weeks of study participation. We enrolled 100 participants from 3/2023-8/2023 and 93 attended the follow-up visit. Thirty-four participants (selected randomly) completed qualitative interviews. The interviews and survey data revealed that cash transfers were primarily used to address basic needs. We identified potential pathways through which cash transfers may improve health, including temporary reductions in stress and anxiety, changes in diet and physical activity, improved medication adherence, and increased healthcare seeking behavior. The intervention itself was viewed as highly acceptable. Participants in the control group were disappointed not to receive the intervention, but felt the process was fair because all participants were economically vulnerable. These findings suggest unconditional cash transfers may improve health for patients with chronic diseases through a variety of pathways that should be measured in future trials.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.